Skip to main content

Intravesical Therapy for Bladder Pain Syndrome/Interstitial Cystitis: Dimethyl Sulfoxide

  • Chapter
  • First Online:
  • 924 Accesses

Abstract

Bladder pain syndrome/interstitial cystitis (BPS/IC) represents a major health burden in the United States and around the world. A recent study (RAND Interstitial Cystitis Epidemiology) estimated that 6.5 % of American women suffer from the disease [1]. Women who were younger or college-educated had greater symptom persistence [2]. Treatment options are broad, from behavioral modification, to oral pharmacologic agents, to intravesical treatments. Intravesical therapy is popular because it spares patients from the systemic effects of oral agents. In this regard, intravesical Dimethyl sulfoxide (DMSO) has been used for many years by urologists in managing these challenging patients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–4. doi:10.1016/j.juro.2011.03.132.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Suskind AM, Berry SH, Suttorp MJ, Elliott MN, Clemens JQ. Symptom persistence in a community cohort of women with interstitial cystitis/bladder pain syndrome (IC/BPS): 3-, 6-, 9-, and 12-month follow-up from the RICE cohort. Int Urogynecol J. 2014;25(12):1639–43. doi:10.1007/s00192-014-2420-z.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Shirley SW, Stewart BH, Mirelman S. DMSO background literature. http://www.dmso.org/articles/bladder/bladder1.htm. Accessed 3 Jun 2015.

  4. Perez-Marrero R, Emerson LE, Feltis J. A controlled study of dimethyl sulfoxide in interstitial cystitis. J Urol. 1988;140(1):36–9.

    CAS  PubMed  Google Scholar 

  5. Peeker R, Haghsheno M-A, Holmäng S, Fall M. Intravesical bacillus calmette-guerin and dimethyl sulfoxide for treatment of classic and nonulcer interstitial cystitis: a prospective, randomized double-blind study. J Urol. 2000;164(6):1912–6.

    Article  CAS  PubMed  Google Scholar 

  6. Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70. doi:10.1016/j.juro.2011.03.064.

    Article  PubMed  Google Scholar 

  7. Ferguson DR, Kennedy I, Burton TJ. ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes–possible sensory mechanism? J Physiol. 1997;505(2):503–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Sun YAN, KEAY S, De DEYNEPG, CHAI TC. Augmented stretch activated adenosine triphosphate release from bladder uroepithelial cells in patients with interstitial cystitis. J Urol. 2001;166(5):1951–6.

    Article  CAS  PubMed  Google Scholar 

  9. Sun Y, Chai TC. Effects of dimethyl sulphoxide and heparin on stretch-activated ATP release by bladder urothelial cells from patients with interstitial cystitis. BJU Int. 2002;90(4):381–5.

    Article  CAS  PubMed  Google Scholar 

  10. Melchior D, Packer CS, Johnson TC, Kaefer M. Dimethyl sulfoxide: does it change the functional properties of the bladder wall? J Urol. 2003;170(1):253–8. doi:10.1097/01.ju.0000071520.73686.3d.

    Article  CAS  PubMed  Google Scholar 

  11. Shiga KI, Hirano K, Nishimura J, Niiro N, Naito S, Kanaide H. Dimethyl sulphoxide relaxes rabbit detrusor muscle by decreasing the Ca2+ sensitivity of the contractile apparatus. Br J Pharmacol. 2007;151(7):1014–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Kim R, Liu W, Chen X, Kreder KJ, Luo Y. Intravesical dimethyl sulfoxide inhibits acute and chronic bladder inflammation in transgenic experimental autoimmune cystitis models. J Biomed Biotechnol. 2011;2011:1–9. doi:10.1155/2011/937061.

    Google Scholar 

  13. Soler R, Bruschini H, Truzzzi J, et al. Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis. Int Braz J Urol. 2008;34(4):503–11.

    Article  PubMed  Google Scholar 

  14. Stout L, Gerspach JM, Levy SM, et al. Dimethyl sulfoxide does not trigger urine histamine release in interstitial cystitis. Urology. 1995;46(5):653–6.

    Article  CAS  PubMed  Google Scholar 

  15. Colaco MA, Evans RJ. Current recommendations for bladder instillation therapy in the treatment of interstitial cystitis/bladder pain syndrome. Curr Urol Rep. 2013;14(5):442–7. doi:10.1007/s11934-013-0369-y.

    Article  PubMed  Google Scholar 

  16. Parkin J, Shea C, Sant G. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis – a practical approach. Urology. 1997;49 Suppl 5:105–7.

    Article  CAS  PubMed  Google Scholar 

  17. Biggers RD. Self-administration of dimethyl sulfoxide (DMSO) for interstitial cystitis. Urology. 1986;28(1):10–1.

    Article  CAS  PubMed  Google Scholar 

  18. Rössberger J, Fall M, Peeker R. Critical appraisal of dimethyl sulfoxide treatment for interstitial cystitis discomfort, side-effects and treatment outcome. Scand J Urol Nephrol. 2005;39(1):73–7. doi:10.1080/00365590410018738.

    Article  PubMed  Google Scholar 

  19. Ghoniem GM, McBride D, Sood OP, Lewis V. Clinical experience with multiagent intravesical therapy in interstitial cystitis patients unresponsive to single-agent therapy. World J Urol. 1993;11(3):178–82.

    Article  CAS  PubMed  Google Scholar 

  20. Smith KJ, Chess-Williams R, McDermott C. Luminal DMSO: effects on detrusor and urothelial/lamina propria function. BioMed Res Int. 2014;2014:1–8. doi:10.1155/2014/347616.

    Google Scholar 

  21. Hung M-J, Chen Y-T, Shen P-S, Hsu S-T, Chen G-D, Ho ES-C. Risk factors that affect the treatment of interstitial cystitis using intravesical therapy with a dimethyl sulfoxide cocktail. Int Urogynecol J. 2012;23(11):1533–9. doi:10.1007/s00192-012-1699-x.

    Article  PubMed  Google Scholar 

  22. Domingue G, Ghoniem G, Bost KL, Fermin C, Human LG. Dormant microbes in interstitial cystitis. J Urol. 1995;153:1321–6.

    Article  CAS  PubMed  Google Scholar 

  23. Stewart B, Branson A, Hewitt C, Kiser W, Straffon R. The treatment of patients with interstitial cystitis, wiht special reference to intravesical DMSO. J Urol. 1972;107(3):377–80.

    CAS  PubMed  Google Scholar 

  24. Stewart B, Shirley S. Further experience with intravesical dimethyl sulfoxide in the treatment of interstitial cystitis. J Urol. 1976;116:36–8.

    CAS  PubMed  Google Scholar 

  25. Fowler J. Prospective study of intravesical dimethyl sulfoxide in treatment of suspected early interstitial cystitis. Urology. 1981;18(1):21–6.

    Article  PubMed  Google Scholar 

  26. Dawson TE, Jamison J. Intravesical treatments for painful bladder syndrome/interstitial cystitis. Cochrane Libr. 2007;4:CD006113. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006113.pub2/full. Accessed 5 Apr 2015.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gamal Ghoniem M.D., F.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Moskowitz, D., Ghoniem, G. (2017). Intravesical Therapy for Bladder Pain Syndrome/Interstitial Cystitis: Dimethyl Sulfoxide. In: Moldwin, R. (eds) Urological and Gynaecological Chronic Pelvic Pain. Springer, Cham. https://doi.org/10.1007/978-3-319-48464-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48464-8_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48462-4

  • Online ISBN: 978-3-319-48464-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics